Anirban Basu

Stergachis Family Endowed Director & Professor of Health Economics

CHOICE Faculty, Department of Pharmacy, Pharmacy Faculty, Plein Center in Geriatrics Faculty, School Faculty

Telephone: (206) 616-2986


Office Location: 1959 NE Pacific Street, Box 357631 H375Q



  • PhD, Public Policy (Health Economics), University of Chicago, 2004
  • MS, Biostatistics, UNC-Chapel Hill, 1999
  • MS, Industrial Pharmacy, University of Toledo, 1997
  • BS, Pharmaceutical Technology, Jadavpur University India

Courses Taught

  • Welfare Economics foundations for cost-effectiveness analysis (HSERV 583, ’11 & ‘12) – 1.5 hour sessions
  • Understanding the role of uncertainty in decision models (HSERV 583, ’13 & ‘14) – 1.5 hour sessions
  • Quantitative methods for valuing information in health care (HSERV 584, ‘11) – 1.5 hour sessions
  • Introduction to comparative effectiveness methods (HSERV 523, ’11; HSERV 513 & HSERV 592, ’12) – 1.5 hour sessions
  • Instrumental variable methods (HSERV 523, ‘11) – 1.5 hour session
  • Financing healthcare (HuBio 555, ’13, ‘14) – 1.5 hour session to 250 2nd year medical students
  • Quantile regression methods (HSERV 525, ’11, HSERV 523, ‘12) – 1.5 hour sessions
  • Variations in healthcare spending: Observations & Implications (PHARM 568, ’14 -‘16) – 1.5 hour sessions
  • Causal inference in observational studies (HSERV 525), Spring 2013 -2019- Ten 3 hour sessions.

Research Interests

  • comparative and cost-effectiveness analyses
  • causal inference methods
  • program evaluation, and outcomes research


Anirban Basu, PhD, MS, is a health economist and a statistician who specializes in research on comparative and cost effectiveness analyses, causal inference methods, program evaluation, and outcomes research. He directs The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington, Seattle, with appointments in the departments of Pharmacy, Health Services, and Economics at the university. He is a Faculty Research Fellow at the National Bureau of Economic Research, and a Fellow of the American Statistical Association. He was one of the panelists for the Second Panel on the Cost-Effectiveness Analysis in Health and Medicine. He studies heterogeneity in clinical and economic outcomes, micro behavior with respect to heterogeneous information, and the value of individualized care. He teaches topics in health economics, decision analysis, cost-effectiveness analysis, and health services research methods. He received his PhD in Public Policy (Health Economics Specialization) from The University of Chicago and an MS in Biostatistics from the University of North Carolina at Chapel Hill.

Selected Publications